why choose us

First received: November 30, 2024

Clinical Trial: The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type 2 Diabetes Mellitus (T2DM)

Study Type: INTERVENTIONAL


Official Title: The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.

Brief Summary: Diabetes mellitus is a progressive endocrine disease characterized by insulin deficiency with or without insulin resistance.Management of type 2 diabetes requires a comprehensive team following and monitoring the disease carefully.Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor, has been shown to be an effective medication for the treatment of T2DM, and has been demonstrated to improve glycemic control.The investigators believe that enrolling clinical pharmacist intervention as a part of a…

Read more